(Date:12/3/2008)...3 The following is a st...ey Hospital Association: , , "State officia...ill share funding from the state,s $44 million Hea...r those facilities, but the more sobering headline...have been turned away. While a worthy effort, clea...
(Date:12/3/2008)...swire/ -- Breast-Specific Gamma Imaging (BSGI) is,...mmographically and clinically,occult (hidden) bre...hnique,that can see lesions independent of tissue...ccording to findings presented today at the annual...rica (RSNA) in this study of women where,breast c...
(Date:12/3/2008)...teeth and antioxidants provide health benefits , ... Today, the average size soft drink is 20 ounces a...is that some citric acids found in fruit drinks ar...-- which is also known as battery acid. These refi...e promote tooth erosion, which wears away the hard...
(Date:12/3/2008)...linked to better education, mental health 15 years...ews) -- Urban kids who took part in a social devel...ental health, sexual health, and educational and e.... , Crime, drug use, teen pregnancy, school dro...llenges faced by many children and families who li...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Identifies Occult Cancer 2Health News:Drink Brewed Tea to Avoid Tooth Erosion 2Health News:Drink Brewed Tea to Avoid Tooth Erosion 3Health News:School-Based Program Can Change Kids' Lives 2(Date:12/3/2008)..., Del., Dec. 3 Isogen, a contract ...erile filling, announced it has retained a,strate... to meet the global,biopharma demand for Isogen,s...d a successful first round series of capital,inve...acility in Q1 2009 to,deliver on the previously u...
(Date:12/2/2008)...O, Dec. 3 Breast-specif...tion of cancers not found on mammograms or by,cli...t the annual meeting of,the Radiological Society ...fy the most difficult to detect breast cancer-inva...F. Brem, M.D., professor of,radiology and directo...
(Date:12/2/2008)...DA, Md., Dec. 2 Micromet...any developing novel, proprietary antibodies for t...e diseases, today announced that it has entered in...ancing Facility (CEFF) with Kingsbridge Capital Li...s of the agreement, Kingsbridge has committed to p...
(Date:12/1/2008)...ORE, Dec. 1 S*BIO Pte Ltd today an...al of SB1518, a potent and orally-active JAK2 inhi... patients with chronic idiopathic myelofibrosis (C...e the safety and tolerability of SB1518 in patient...ents. The Phase 1 part of the study will assess t...
Breaking Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 1Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 2Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 3Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 4Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 5Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 6Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 7Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 8Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 9Cardium Announces FDA 510 28K 29 Clearance of InnerCools RapidBlue 28TM 29 Endovascular System 8387 10Study 3A Wildlife need more complex travel plans 5464 1Beckman Coulter Declares Quarterly Dividend Payout of 240 17 Per Share 8385 1Pesticide concentrations decreasing 5460 1Pesticide concentrations decreasing 5460 2...LDER, Colo.--(BUSINESS WIRE)--Jun 20, 2007 - Array... 1 clinical data on its MEK,inhibitor, ARRY-162, a... presented at the Annual European Congress of Rheu...nternational Association,of Inflammation Societies...enhagen, Denmark., ARRY-162 / MEK Inhibitor Phase ...
...ENNA, Va., June 20, 2007 /PRNewswire/ -- Modigene ...cessful completion of,pharmacokinetic and pharmaco...uman growth hormone, long-acting interferon beta a...codynamic and pharmacokinetic pre-clinical,experim...ting,proteins, indicating a potential administrati...
Other Medicine Technology:Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs 2Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs 3Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs 4Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 2Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 3Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 4...2255 rotary microtome, designed for fully motorize...specimens, offers a broad application spectrum for...is microtome meets the requirements of users looki...tome for their laboratory. The entire accessory li...
State-of-the-Art modular embedding station providing performance and ease of use to meet the needs of the most demanding user.
...stem for specimen surface preparation is the Leica...achment Leica SP2600. ,Ultramilling is often a v...crotomy in sample preparation. Especially with dif...e located side by side in one specimen block, the ...
ACRYSOF®, Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are i
Medicine Products: